These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11858563)

  • 21. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.
    Goossens LM; Riemersma RA; Postma DS; van der Molen T; Rutten-van Mölken MP
    Adv Ther; 2009 Sep; 26(9):872-85. PubMed ID: 19768640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) for the treatment of asthma.
    Rosenhall L; Elvstrand A; Tilling B; Vinge I; Jemsby P; Ståhl E; Jerre F; Bergqvist PB
    Respir Med; 2003 Jun; 97(6):702-8. PubMed ID: 12814158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland*.
    Tamminen K; Laine J; Soini E; Martikainen J; Kankaanranta H
    Curr Med Res Opin; 2008 Dec; 24(12):3453-61. PubMed ID: 19032127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma.
    Ställberg B; Ekström T; Neij F; Olsson P; Skoogh BE; Wennergren G; Löfdahl CG;
    Respir Med; 2008 Oct; 102(10):1360-70. PubMed ID: 18723335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Audit of budesonide/formoterol prescribing for asthma in community pharmacy in the U.K.
    Boyter AC; Ford NH; Zlotos L
    Respir Med; 2011 Jun; 105(6):864-8. PubMed ID: 21227673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Budesonide + formoterol delivered via Spiromax
    Lewis A; Torvinen S; Dekhuijzen PNR; Chrystyn H; Melani A; Zöllner Y; Kolbe K; Watson AT; Blackney M; Plich A
    Respir Med; 2017 Aug; 129():179-188. PubMed ID: 28732829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma.
    Bisgaard H; Le Roux P; Bjåmer D; Dymek A; Vermeulen JH; Hultquist C
    Chest; 2006 Dec; 130(6):1733-43. PubMed ID: 17166990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
    Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.
    Tal A; Simon G; Vermeulen JH; Petru V; Cobos N; Everard ML; de Boeck K
    Pediatr Pulmonol; 2002 Nov; 34(5):342-50. PubMed ID: 12357478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation].
    Zyryanov SK; Dyakov IN; Aisanov ZR
    Ter Arkh; 2022 Aug; 94(7):850-858. PubMed ID: 36286942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.
    Aballéa S; Cure S; Vogelmeier C; Wirén A
    Int J Clin Pract; 2008 Dec; 62(12):1870-9. PubMed ID: 18803555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of budesonide-formoterol vs inhaled epinephrine in US adults with mild asthma.
    Ho JK; Shaker M; Greenhawt M; Sadatsafavi M; Abrams EM; Oppenheimer J; Mosnaim GS; Lee TY; Johnson KM
    Ann Allergy Asthma Immunol; 2024 Feb; 132(2):229-239.e3. PubMed ID: 37879568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Budesonide and formoterol in a single inhaler controls asthma in adolescents.
    Pohunek P; Tal A
    Int J Adolesc Med Health; 2004; 16(2):91-105. PubMed ID: 15266989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries.
    Lewis A; Torvinen S; Dekhuijzen PN; Chrystyn H; Watson AT; Blackney M; Plich A
    BMC Health Serv Res; 2016 Jul; 16():251. PubMed ID: 27406133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness and safety of adjustable maintenance dosing with budesonide/formoterol turbuhaler compared with traditional fixed doses in bronchial asthma: a multi-centre Nigerian study.
    Ige OM; Ohaju-Obodo JO; Chukwu C; Peters EJ; Okpapi J; Chukwuka C
    Afr J Med Med Sci; 2010 Sep; 39(3):165-72. PubMed ID: 21416785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain.
    Quirce S; Barcina C; Plaza V; Calvo E; Muñoz M; Ampudia R; Capel M
    J Asthma; 2011 Oct; 48(8):839-47. PubMed ID: 21942354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adding formoterol to budesonide in moderate asthma--health economic results from the FACET study.
    Andersson F; Stahl E; Barnes PJ; Löfdahl CG; O'Byrne PM; Pauwels RA; Postma DS; Tattersfield AE; Ullman A;
    Respir Med; 2001 Jun; 95(6):505-12. PubMed ID: 11421509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An economic evaluation of combination treatment with budesonide and formoterol in patients with mild-to-moderate persistent asthma.
    Jönsson B; Berggren F; Svensson K; O'Byrne PM
    Respir Med; 2004 Nov; 98(11):1146-54. PubMed ID: 15526817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
    van der Woude HJ; Boorsma M; Bergqvist PB; Winter TH; Aalbers R
    Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.